期刊文献+

热休克凋亡食管癌细胞负载自体树突状细胞制备及其表型特征的分析 被引量:8

Preparation and characterize of autologous dendritic cells loaded by heat shocked apoptotic esophagus cancer cells
原文传递
导出
摘要 目的:建立自体热休克凋亡食管癌细胞抗原制备、树突状细胞(DC)体外诱导以及抗原负载方法,为DC肿瘤疫苗的临床应用提供技术基础。方法:采用酶消化法从手术切除的食管癌新鲜组织获得单细胞悬液,热休克后用桦脂酸诱导其凋亡制备成细胞抗原;采用人工肝素抗凝采集外周静脉血,分离单个核细胞(PBMC),贴壁法获得单核细胞,经GM-CSF与IL-4体外诱导成未成熟树突状细胞(imDC);负载细胞抗原后制备成DC肿瘤疫苗,并对DC疫苗的形态、数量及表型特征进行分析。结果:肿瘤细胞抗原每克组织得率(9.89±2.46)×106,平均凋亡率(67.60±3.23)%。imDC活率>95%,imDC表型分析为CD11c+HLA-DR+、CD11c+CD80+、CD11c+CD83+和CD11c+CD86+,表达率分别为(88.30±3.59)%(、1.25±0.55)%、(6.13±1.79)%和(72.90±5.01)%。DC疫苗活率>95%,DC疫苗表型为CD11c+HLA-DR+、CD11c+CD80+、CD11c+CD83+和CD11c+CD86+,表达率分别为(89.60±3.91)%、(34.20±3.85)%、(64.90±8.05)%和(86.10±6.22)%。负载自体抗原DC诱导CTL杀伤自体肿瘤细胞的杀伤率为(65.90±6.25)%,明显高于杀伤食管癌肿瘤细胞株的杀伤率〔(32.56±2.68)%〕,P<0.01。结论:本方法稳定、安全及可靠,可制备出在体外诱导特异性CTL的DC肿瘤疫苗。 OBJECTIVE:To establish a method for the preparation of heat shocked esophagus cancer cells antigen,and autologous dendritic cell(DC) induced in vitro including the antigen loading.METHODS: Single cell suspension was obtained from the surgical fresh tissues of esophagus cancer by enzyme digestion,and then the cell antigen was prepared through apoptosis induced by betulinic acid after heat shock.The peripheral venous blood was collected under anticoagulation adopting artificial heparin,and the separated peripheral blood mononuclear cells(PBMC) by adherent methods were induced into immature DC(imDC) by GM-CSF and interleukin IL-4 in vitro.DC tumor vaccine was prepared following cell antigen loading,and then the DC tumor vaccine's configuration,quantity,and phenotype character were analyzed.RESULTS:Tumor cell antigen gaining-rate was(9.89±2.46)×106 per gram tissue and average apoptotic rate was(67.60±3.23)%.imDC's viability was more than 95%.The imDC phenotype character analysis showed that the expression rate of CD11c+ HLA-DR+,CD11c+ CD80+,CD11c+ CD83+ and CD11c+ CD86+ were(88.30±3.59)%,(1.25±0.55)%,(6.13±1.79)%,(72.90±5.01)%,respectively.DC vaccine's viability was more than 95%.The DC phenotype character analysis showed that the expression rates of CD11c+ HLA-DR+,CD11c+ CD80+,CD11c+ CD83+,and CD11c+ CD86+ were(89.60±3.91)%,(34.20±3.85)%,(64.90±8.05)% and(86.10±6.22)%,respectively.The CTLs induced by autologous antigen loaded DC was significantly higher against autologous tumor cells((65.90±6.25)%) than that against tumor cell lines((32.56±2.68)%,P0.01).CONCLUSIONS: The method for autologous dendritic cells loaded by heat shocked apoptotic esophagus cancer cells is of stabilization,security and credibility.The mature DC tumor vaccines can be prepared for the potential clinical application.
出处 《中华肿瘤防治杂志》 CAS 2011年第2期98-101,共4页 Chinese Journal of Cancer Prevention and Treatment
关键词 食管肿瘤/免疫学 癌症疫苗/免疫学 抗原 CD 树突细胞/免疫学 esophageal neoplasms/immuneologic cancer vaccines/immuneologic antigens CD dendriteic cells/immuneologic
  • 相关文献

参考文献11

  • 1Jefford M, Maraskovsky E, Cebon J, et al. The use of dendritic cells in cancer therapy[J].LancetOncol, 2001, 2(6): 343 353.
  • 2Gliboa E. DC-based cancer vaccines[J].J Clin Invest, 2007, 117(5) : 1195-1203.
  • 3Moiseyenko V, Imyanitov E, Danilova A, et al. Cell technolo gies in immunotherapy of cance[J].Adv Exp Med Biol, 2007, 601(8) : 387-393.
  • 4Vulink A, Radord K J, Melief C, et ah Dendritic ceils in cancer imrnunotherapy[J].Annu Rev Immunol, 2000, 18 (1) : 245-273.
  • 5Sadanaga N, Nagashima H, Mashino K. Dendritic cell vaccination with MAGE peptide is a novel therapeutic approach for gastrointesti nal carcinomas[J]. Clin Cancer Res, 2001, 7(8):2277 2284.
  • 6Kanaoka S, Yamasaki S, Okino T, et al. lncluctlon oI numail leukocyte antigen (HLA)-A2 restricted and MAGE g gene-derived peptide specific cytolytic T lymphocytes using cultured dendritic eel, is an HL.k-AZ esophagea[ cancer patient[J]. J Surg Oncol, 1999, 71(1):16-21.
  • 7Shi H Z, Cao T, Connolly J E, et al. Hyperthermia enhances CTL Cross Priming [J].The Journal of Immunology, 2006, 176(4) : 2134-2141.
  • 8孟淑芳,林林,李修兰,冯建平,王佑春,李德富.软琼脂克隆法与裸鼠体内接种法检测细胞致瘤性的比较[J].中国生物制品学杂志,2006,19(5):516-519. 被引量:21
  • 9Paczesny S, Shi H Z, Satio H, et al. Measuring melanoma specific cytotoxic T lymphocytes elicited by dendritic cell vaccines with a tumor inhibition assay in vitro[J]. J Immunother, 2005, 28(2):148-157.
  • 10赵增仁 李勇 田延峰.以树突状细胞为基础个体化抗胃癌过继免疫治疗的研究.第四军医大学学报,2008,29(12):1008-1091.

二级参考文献6

  • 1WHO Technical Report Series,No.878,1998,Annex 1:Requirements for the used of animal cells as in vitro substrated for the production of biologicals.
  • 2Davis JM.Basic cell culture.Oxford University Press,2002.
  • 3FDA.Points to consider in the characterization of cell lines used to produce biologicals.1993.
  • 4Hirose K,Hakozaki N,Nyunova Y,et al.Chemokine gene transfection into tumout cells reduced tumorigenicity in nude mice in association with neurtrophilic infiltration.Br J Cancer,1995,72 (3):708-714.
  • 5Vincent-Falquet JC,Peyron L,Souvras M,et al.Qualification of working cell banks for the vero cell line to produce licensed human vaccines.Developments in Biological Standardization,1989,70:153-156.
  • 6Petricciani JC,Levenbook IS,Wierenga DE,et al.Early passage primate cell immotality is independent of tumorigenicity.In Vitro Cell Dev Biol,1987,23(7):523-526.

共引文献21

同被引文献91

  • 1张志明,刘剑勇,赵荫农,袁卫平,张力图,张春燕,李挺.树突状细胞激活的肿瘤浸润性淋巴细胞体外特异性抗小鼠肝癌研究[J].中华肝胆外科杂志,2005,11(8):547-550. 被引量:4
  • 2王同国,史斌.热休克蛋白调控的研究进展[J].现代免疫学,2007,27(1):73-76. 被引量:11
  • 3刘运江,张建立,单保恩.负载乳腺癌细胞冻融抗原的DC对CTL体外特异性杀伤活性的影响[J].中国免疫学杂志,2007,23(8):693-696. 被引量:4
  • 4Rolinski J, Hus I. Dendritic-cell tumor vaccines[J].Transplant Proc, 2010,42 (8) : 3306-3308.
  • 5Kikuchi T, Moore MA, Crystal RG. Dendritic cells modified to express CD40 ligand elicit therapeutic immunity against preexist- ing murine tumors[J]. Blood, 2000,96 ( 1 ) : 91-99.
  • 6Yilmaz T,Gedikoglu G, Celik A, et al. Prognostic significance of langerhans cell infiltration in cancer of the laryn[J].Otolaryn- gol Head Neck Surg,2005,132(2) :309-316.
  • 7Gigante M,Blasi A,Loverre A,et al. Dysfunctional DC subsets in RCC patients:ex vivo correction to yield an effective anti-cancer vaccine[J].Mol Immunol,2009,46(5) :893-901.
  • 8Ranieri E, Gigante M, Storkus WJ, et al. Translational mini-re- view series on vaccines., dendritic cell-based vaccines in renal cancer[J]. Clin Exp Immunol, 2007,147 (3) : 395-400.
  • 9Morandi F, Chiesa S, Bocca P, et al. Tumor mRNA-transfected dendritic cells stimulate the generation of CTL that recognize neuroblastoma-associated antigens and kill tumor cells:immuno- therapeutic implications[J]. Neoplasia, 2006,8 (10) : 833-842.
  • 10Nencioni A,Grtinebach F,Schmidt SM. The use of dendritic cells in cancer immunotherapy[J]. Crit Rev Oncol Hematol, 2008,65(3) :191.

引证文献8

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部